Literature DB >> 29623657

A case of primary familial congenital polycythemia with a novel EPOR mutation: possible spontaneous remission/alleviation by menstrual bleeding.

Naohisa Toriumi1, Makoto Kaneda2, Naoki Hatakeyama1, Hiromi Manabe3, Kazuki Okajima1, Yukari Sakurai1, Masayo Yamamoto4, Takeo Sarashina1, Katsuya Ikuta4, Hiroshi Azuma5.   

Abstract

A 10-year-old girl with persistent erythrocytosis and ruddy complexion was diagnosed with primary familial congenital polycythemia (PFCP) involving a novel heterozygous mutation of c.1220C>A, p.Ser407X in exon 8 of the erythropoietin receptor gene (EPOR). This mutation causes truncation of EPOR, resulting in loss of the cytoplasmic region, which is necessary for negative regulation of erythropoietin signal transmission. Genetic analysis showed that the mutated EPOR was inherited from her mother. Her mother had polycythemia and had undergone venesection several times when she was young, but her polycythemic state appeared to have resolved. Venesection was not needed to maintain Hct levels within normal range. For the case reported here, venesection was also conducted to maintain the blood Hct level below 50%. We observed that after the patient experienced menarche, the volume and frequency of venesection needed to maintain Hct level < 50% were clearly reduced compared with those before menarche. These findings suggest that, in female patients with this type of EPOR mutation, menstruation might reduce blood volume in a manner similar to venesection. Spontaneous remission of erythrocytosis may thus occur after the start of menstrual bleeding.

Entities:  

Keywords:  EPOR; Menarche; Menstruation; PFCP; Phlebotomy

Mesh:

Substances:

Year:  2018        PMID: 29623657     DOI: 10.1007/s12185-018-2435-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  9 in total

1.  Two novel missense mutations in EPOR gene causes erythrocytosis in two unrelated patients.

Authors:  Edoardo Peroni; Irene Bertozzi; Filippo Gherlinzoni; Piero M Stefani; AnnaMaria Lombardi; Giacomo Biagetti; Fabrizio Fabris; Maria L Randi
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

2.  Genetic basis of congenital erythrocytosis: mutation update and online databases.

Authors:  Celeste Bento; Melanie J Percy; Betty Gardie; Tabita Magalhães Maia; Richard van Wijk; Silverio Perrotta; Fulvio Della Ragione; Helena Almeida; Cedric Rossi; François Girodon; Maria Aström; Drorit Neumann; Susanne Schnittger; Britta Landin; Milen Minkov; Maria Luigia Randi; Stéphane Richard; Nicole Casadevall; William Vainchenker; Susana Rives; Sylvie Hermouet; M Leticia Ribeiro; Mary Frances McMullin; Holger Cario; Aurelie Chauveau; Anne-Paule Gimenez-Roqueplo; Brigitte Bressac-de-Paillerets; Didem Altindirek; Felipe Lorenzo; Frederic Lambert; Harlev Dan; Sophie Gad-Lapiteau; Ana Catarina Oliveira; Cédric Rossi; Cristina Fraga; Gennadiy Taradin; Guillermo Martin-Nuñez; Helena Vitória; Herrera Diaz Aguado; Jan Palmblad; Julia Vidán; Luis Relvas; Maria Leticia Ribeiro; Maria Luigi Larocca; Maria Luigia Randi; Maria Pedro Silveira; Melanie Percy; Mor Gross; Ricardo Marques da Costa; Soheir Beshara; Tal Ben-Ami; Valérie Ugo
Journal:  Hum Mutat       Date:  2013-10-22       Impact factor: 4.878

3.  Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state.

Authors:  S S Watowich; X Xie; U Klingmuller; J Kere; M Lindlof; S Berglund; A de la Chapelle
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

4.  Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor.

Authors:  T Furukawa; M Narita; M Sakaue; T Otsuka; T Kuroha; M Masuko; T Azegami; K Kishi; M Takahashi; J Utsumi; T Koike; Y Aizawa
Journal:  Br J Haematol       Date:  1997-10       Impact factor: 6.998

5.  A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis.

Authors:  Murat O Arcasoy; Aysen F Karayal; Harvey M Segal; Joseph G Sinning; Bernard G Forget
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

6.  A novel mutation of the erythropoietin receptor gene associated with primary familial and congenital polycythaemia.

Authors:  Kacey O'Rourke; David J Fairbairn; Kathryn A Jackson; Kirk L Morris; Siok-Keen Tey; Glen A Kennedy
Journal:  Int J Hematol       Date:  2011-03-25       Impact factor: 2.490

7.  Molecular genetic analyses in familial and sporadic congenital primary erythrocytosis.

Authors:  Susana Rives; Heike L Pahl; Lourdes Florensa; Beatriz Bellosillo; Andrea Neusuess; Jesus Estella; Klaus-Michael Debatin; Elisabeth Kohne; Klaus Schwarz; Holger Cario
Journal:  Haematologica       Date:  2007-05       Impact factor: 9.941

Review 8.  Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.

Authors:  Lily J Huang; Yu-Min Shen; Gamze B Bulut
Journal:  Br J Haematol       Date:  2010-01-20       Impact factor: 6.998

9.  Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin.

Authors:  L Sokol; M Luhovy; Y Guan; J F Prchal; G L Semenza; J T Prchal
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

  9 in total
  3 in total

1.  Discrepancy in the degree of polycythemia in a family with a novel nonsense EPOR mutation.

Authors:  Chitsanupong Ratarat; Chupong Ittiwut; Rungrote Natesirinilkul; Lalita Sathitsamitpong; Kanda Fanhchaksai; Pimlak Charoenkwan; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  Int J Hematol       Date:  2019-07-26       Impact factor: 2.490

Review 2.  Erythrocytosis: genes and pathways involved in disease development.

Authors:  Jernej Gašperšič; Aleša Kristan; Tanja Kunej; Irena Preložnik Zupan; Nataša Debeljak
Journal:  Blood Transfus       Date:  2020-12-16       Impact factor: 3.443

3.  Effects of idiopathic erythrocytosis on the left ventricular diastolic functions and the spectrum of genetic mutations: A case control study.

Authors:  Alpay Yesilaltay; Hasan Degirmenci; Turker Bilgen; Duygu Yasar Sirin; Duygu Bayir; Pelin Degirmenci; Atakan Tekinalp; Seref Alpsoy; Yildiz Okuturlar; Burhan Turgut
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.